Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank86
3Y CAGR+4.8%
5Y CAGR-30.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+4.8%/yr
vs +18.4%/yr prior
5Y CAGR
-30.6%/yr
Recent acceleration
Acceleration
-13.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $35.26M | +182.6% |
| 2024 | $12.47M | -50.7% |
| 2023 | $25.29M | -17.4% |
| 2022 | $30.61M | -3.8% |
| 2021 | $31.83M | -85.4% |
| 2020 | $218.31M | +1056.4% |
| 2019 | $18.88M | +21.1% |
| 2018 | $15.60M | - |